The landscape of diabetes care is advancing with the arrival of skin-applied GLP-1 therapy. These innovative devices offer a possibly more comfortable alternative to shots for individuals living with type 2 diabetes . They deliver glucagon-like peptide-1 directly through the epidermis, circumventing